News Releases

September 06, 2021
Taiho Pharmaceutical Co., Ltd.

Taiho Pharmaceutical Relocates Head Office

Taiho Pharmaceutical Co., Ltd. today announced that it has moved its head office to a new building at 1-27 Kandanishiki-cho, Chiyoda-ku, Tokyo.

New address

1-27 Kandanishiki-cho, Chiyoda-ku, Tokyo, 101-8444, Japan



* An automated voice guidance system has been introduced.
* The telephone number will not be changed.

Nearby Stations

⦿ Otemachi Station : Approx. 3-minute walk from C2b Exit
⦿ Ogawamachi and Awajicho Station:Approx. 5-minute walk from B7 Exit
⦿ Takeshiba Station:Approx. 7-minute walk from No.4 Exit
⦿ JR Kanda Station:Approx. 9-minute walk from West Exit

The address for the head office and principal office for manufacturing and sales divisions listed in registration will not be affected by the relocation.

Information in this news release was current as of the original release date.

Taiho Pharmaceutical's press releases may contain information about prescription drugs including products currently under development, however information contained in the press releases are not intended to constitute promotion, advertisement, or medical advice.